Comprehensive overview of biomarkers to predict response to immune checkpoint therapy in lung cancer

Immune checkpoint (IC) therapy has brought a huge revolution in the field of lung cancer treatment over the past decade. It has also revolutionised treatment paradigm and has tremendously improved patient prognosis. IC inhibitors (ICIs) targeting Programmed Cell Death Protein 1/Programmed cell death...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Kriti Jain, Deepa Mehra, Nirmal Kumar Ganguly, Rashmi Rana, Surajit Ganguly, Shyam Aggarwal
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Wolters Kluwer Medknow Publications 2023-01-01
سلاسل:	Current Medicine Research and Practice
الموضوعات:	biomarkers immune checkpoint inhibitors immunotherapy lung cancer pd-1/pd-l1 antibodies
الوصول للمادة أونلاين:	http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2023;volume=13;issue=5;spage=232;epage=242;aulast=Jain
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!